Bipolar Disorder and Addiction Treatment in Roanoke, VA.

Bipolar disorder and substance use disorder is one of the most clinically complex combinations we treat. Both conditions are episodic. Both involve significant neurobiological changes. Both produce behavior that family members often misread for years before the clinical picture comes into focus. And both feed each other in ways that make either one harder to treat in isolation.

People with bipolar I disorder develop substance use disorders at rates significantly higher than the general population, and the combination produces meaningful complications for mood stabilization, medication management, and recurrence risk.

At Roanoke Refuge, co-occurring bipolar disorder and substance use disorder are treated as substance-use-primary outpatient care where co-occurring mental health conditions are addressed inside the same treatment plan. The work runs across PHP, IOP, and Telehealth IOP, with close coordination with outside psychiatric prescribers. The broader dual diagnosis program describes the integrated structure in more depth.

What Bipolar Disorder Is

Bipolar disorder is a mood disorder characterized by episodes of elevated mood, called mania or hypomania, alternating with episodes of depression. The American Psychiatric Association recognizes several bipolar disorder diagnoses, including bipolar I disorder, defined by at least one manic episode and typically including depressive episodes, and bipolar II disorder, defined by at least one hypomanic episode and at least one major depressive episode without full mania. Cyclothymic disorder describes a less severe but chronic pattern of mood fluctuation.

A manic episode is more than feeling good. The DSM-5 criteria include a distinct period of abnormally elevated, expansive, or irritable mood lasting at least one week, along with three or more of these symptoms:

A major depressive episode involves at least five of the depressive symptoms criteria, including depressed mood or loss of interest, present most of the day, nearly every day, for at least two weeks. The depressive episodes of bipolar disorder often look clinically similar to major depressive disorder, which is why bipolar II disorder in particular is frequently misdiagnosed as unipolar depression for years before the correct diagnosis is made.

What the Research Shows on Bipolar and Substance Use

The co-occurrence of bipolar disorder and substance use disorder is among the most consistently documented findings in dual diagnosis research. The National Institute of Mental Health and the National Institute on Drug Abuse, along with major reviews including the National Comorbidity Survey Replication, have established that people with bipolar disorder develop substance use disorders at substantially elevated rates compared to the general population.

Estimates vary by study, methodology, and population, but the consistent finding is that a majority of people with bipolar I disorder will meet criteria for a substance use disorder over the lifetime.

The relationship between the two conditions is bidirectional and complex. Mood episodes increase the risk of substance use through impulsivity, attempts at self-medication, and the disinhibition of mania. Substance use worsens mood instability, complicates medication management, and increases the risk of recurrent mood episodes. The two conditions are not running in parallel. They are tangled together in ways that integrated treatment is designed to address.

The Self-Medication Pattern

The most common clinical pattern we see in co-occurring bipolar disorder and substance use disorder involves some version of self-medication, where substances are used to manage the symptoms of mood episodes. The substances vary by episode and by person:

The pattern is understandable and clinically damaging. Each substance provides short-term relief from intolerable symptoms while making the underlying disorder worse. Alcohol disrupts sleep architecture, which is critical for mood stabilization. Stimulants can precipitate manic episodes. Cannabis is associated with worse outcomes in bipolar disorder across multiple studies. The self-medication often begins as a way to make the disorder bearable and ends as a separate disorder that requires its own clinical attention.

How We Treat Co-Occurring Bipolar and Substance Use at Roanoke Refuge

Treating bipolar disorder and substance use disorder together is the standard of care. The seven operational elements below shape what that looks like at Roanoke Refuge, with evidence-based therapies (CBT, DBT skills, Motivational Interviewing) running alongside on-site MAT and psychiatric coordination.

The Medication Coordination Challenge

Mood stabilization in bipolar disorder typically requires consistent medication, and the medication plan often includes lithium, valproate, lamotrigine, certain antipsychotics, and other agents depending on the clinical picture. Active substance use complicates medication management in several specific ways:

The clinical implication is that medication coordination between the addiction treatment team and the psychiatric prescriber is not optional. Our clinical team works closely with outside prescribers to ensure the medication plan is integrated with the substance use disorder treatment, that medication adherence is supported, and that any changes in clinical picture are communicated between providers.

Suicidality and Bipolar Disorder

Bipolar disorder is associated with significantly elevated suicide risk compared to the general population, and co-occurring substance use disorder elevates the risk further. The intake assessment at Roanoke Refuge includes thorough suicide risk screening using validated tools, and clinical staff are trained in risk assessment and safety planning. Active suicidality may indicate the need for a higher level of care than outpatient programming, including inpatient psychiatric stabilization, and the admissions team makes those level-of-care recommendations based on the current clinical picture.

Distinguishing Bipolar From Substance-Induced Mood Episodes

One of the most clinically challenging questions in dual diagnosis work is distinguishing primary bipolar disorder from substance-induced mood symptoms that look similar in the moment. Stimulant use can produce symptoms that look like hypomania or mania. Alcohol withdrawal can produce symptoms that look like depression or mixed states. Cannabis use is associated with episodes that can look like both.

The distinction often becomes clear only across weeks to months of sustained abstinence, with longitudinal observation of mood patterns, family history, and the timing of episodes. Our clinical team holds the diagnostic picture lightly in the early phase of treatment and refines it as the picture clears.

Some clients arrive with a bipolar diagnosis that does not hold up in sustained sobriety and turns out to have been substance-induced. Others arrive without a bipolar diagnosis and develop a clearer clinical picture during treatment that supports the diagnosis. Either way, the diagnostic work is part of the clinical process, and the treatment plan adapts as the picture clarifies.

Integration With Other Treatment Elements

Co-occurring bipolar disorder and substance use disorder is treated within the broader dual diagnosis framework. Co-occurring disorders describes the substance-use-primary treatment model that underlies the work. Clients receive the full range of evidence-based therapies including CBT, DBT skills, group therapy, and trauma-informed care applied to their specific clinical picture. Family members are involved through the Family Programthrough clinical family therapy sessions where indicated.

Roanoke Refuge prescribes FDA-approved MAT medications on-site. Mood stabilizers, antipsychotics, and any other psychiatric pharmacotherapy that is part of the substance-use-primary care with co-occurring mental health addressed in the same plan plan are coordinated with community prescribers across the Roanoke region — your existing psychiatrist, primary care physician, or a new prescriber we can connect you with during admissions.

Levels of Care and Getting Started

Treatment runs substance-use-primary, with the bipolar disorder addressed inside the same plan delivered across our outpatient levels of care. PHP at full-day outpatient offers the most intensive structure for clients who need significant clinical support without inpatient admission. IOP at part-day outpatient provides nine or more hours weekly. Telehealth IOP delivers the same curriculum virtually for clients across Southwest Virginia where the commute is a barrier.

For clients with currently unstable bipolar disorder, acute suicidality, or other clinical features that exceed the scope of outpatient programming, the admissions team will recommend a higher level of care. The recommendation is made based on the current clinical picture and the clinical assessment, with attention to both the substance use and the mood disorder.

The path in begins with a confidential conversation with our admissions team. The first call covers the substance use history, the mood disorder history, the current medication regimen, the current symptoms, and the level of care that fits the clinical assessment. What to expect walks through the steps between the first call and the first day. Insurance verification runs alongside the clinical conversation at no cost.

Local, regional, and accessible.

Roanoke Refuge serves clients from across the Roanoke Valley — Roanoke City, Salem, Vinton, and the surrounding counties of Roanoke County, Botetourt County, and Bedford County. Our facility at 1630 Braeburn Drive in Salem sits just off I-81 exit 137, a short drive from downtown Roanoke via I-581 South and accessible from most of the Valley within 20 to 30 minutes. Whether you live near the Mill Mountain Star or out toward the Blue Ridge Parkway, the outpatient model is the same.

If a co-occurring condition alongside a substance use disorder is the picture for you or someone you love, the first step is a conversation, not a commitment. A short call with the Roanoke Refuge admissions team covers fit, level of care, and insurance — before any clinical work begins. Free, confidential insurance verification runs during the same call. Call (540) 900-0353 when you are ready.